WCM
CGON icon

Winthrop Capital Management’s CG Oncology CGON Stock Holding History

Winthrop Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Hold
1,467
– – 0.03% 149
2026
Q1 		$99K Hold
1,467
– – 0.03% 150
2025
Q4 		$61K Hold
1,467
– – 0.01% 177
2025
Q3 		$59K Hold
1,467
– – 0.01% 163
2025
Q2 		$38K Buy
+1,467
New +$35.4K 0.01% 190

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winthrop Capital Management's CGON Position: Q2 2026 in Review

Winthrop Capital Management held its CG Oncology (CGON) position steady in Q2 2026 at 1,467 shares worth $104K. The position accounts for 0.03% of the portfolio, ranked #149.

Winthrop Capital Management first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Winthrop Capital Management held 1,467 shares of CG Oncology worth $104K as of Q2 2026.
  • Winthrop Capital Management left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up 0.03% of Winthrop Capital Management's portfolio in Q2 2026, its #149 holding.
  • Winthrop Capital Management first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.